Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis
- 31 May 2008
- journal article
- clinical trial
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 61 (1) , 13-20
- https://doi.org/10.1016/j.diagmicrobio.2008.01.010
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC valuesDiagnostic Microbiology and Infectious Disease, 2007
- Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitisDiagnostic Microbiology and Infectious Disease, 2007
- Use of Pharmacodynamic End Points in the Evaluation of Gatifloxacin for the Treatment of Acute Maxillary SinusitisClinical Infectious Diseases, 2004
- Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilutionJournal of Applied Physiology, 1986
- A Confidence Interval for the Median Survival TimePublished by JSTOR ,1982